US 11447563
Tumor selective macropinocytosis-dependent rapidly internalizing antibodies
granted A61KA61K45/06A61K47/6801
Quick answer
US patent 11447563 (Tumor selective macropinocytosis-dependent rapidly internalizing antibodies) held by The Regents of the University of California expires Mon Sep 15 2042 00:00:00 GMT+0000 (Coordinated Universal Time). Status: granted.
Key facts
- Applicant
- The Regents of the University of California
- Grant date
- Tue Sep 20 2022 00:00:00 GMT+0000 (Coordinated Universal Time)
- Expiration
- Mon Sep 15 2042 00:00:00 GMT+0000 (Coordinated Universal Time)
- Claims
- 19
- CPC classes
- A61K, A61K45/06, A61K47/6801, A61K47/6851, A61K47/6889